The first stem cell company to post a quarterly profit, Osiris Therapeutics (OSIR) may also be...

|About: Osiris Therapeutics, Inc. (OSIR)|By:, SA News Editor

The first stem cell company to post a quarterly profit, Osiris Therapeutics (OSIR) may also be the only profitable one in its field for a long time to come. With shares up 33% this year, says one analyst, ''you've got Osiris and you've got everybody else.'